Ji-Wang Chern

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 3

Top Topics

Pluripotent Stem Cells

Cardiovascular Risk Factors

Structural Basis

Histone Deacetylase

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Wei-Chieh Yu, Tsung-Yu Yeh, Chih-Hung Ye, Patrick Chun Theng Chong, Yi-Hsun Ho, Dorothy Kazuno So, Kah Yi Yap, Guan-Ru Peng, Chi-Hsuan Shao, Ajit Dhananjay Jagtap, Ji-Wang Chern, Chen-Si Lin, Shau-Ping Lin, Shuei-Liong Lin, Shu-Han Yu, Chao-Wu Yu
Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis. Journal of medicinal chemistry (2023)
Chao-Ming Hsieh, Chun-Yi Chen, Ji-Wang Chern, Nei-Li Chan
Structure of Human Phosphodiesterase 5A1 Complexed with Avanafil Reveals Molecular Basis of Isoform Selectivity and Guidelines for Targeting α-Helix Backbone Oxygen by Halogen Bonding. Journal of medicinal chemistry 63 (15) (2020)
Chao-Wu Yu, Pei-Yun Hung, Hui-Ting Yang, Yi-Hsun Ho, Hsing-Yi Lai, Yi-Sheng Cheng, Ji-Wang Chern
Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer. Journal of medicinal chemistry 62 (2) (2018)